
Wed Jan 08 05:03:13 UTC 2025: ## Merck’s HPV Vaccine Approved for Boys in China
**Beijing, January 8, 2025** – US pharmaceutical giant Merck & Co. announced today that China’s medical products administration has approved its human papillomavirus (HPV) vaccine for boys aged 9 to 26. The announcement, made via Chinese social media, marks a significant step in expanding HPV vaccination efforts in the country. This approval covers the male population within the specified age range.